Sanofi annonce les résultats positifs d'une étude de prolongation de phase III de Toujeo® chez des patients japonais atteints de diabète non contrôlé
La Gazette du Laboratorie,
Toujeo approved in the European Union for the treatment of diabetes in adults
Medical News Today,
Sanofi has announced that the European Commission has granted marketing authorization in Europe for Toujeo® (insulin glargine [rD…
Toujeo Receives Positive Opinion from the European Regulatory Authorities
Bioportfolio,
Toujeo Receives Positive Opinionfrom the European Regulatory Authorities Paris France February 27 2015 Sanofi announced today…